Medikamentenvergleiche
Insulin Regular Human vs. Rosiglitazone
Compare regular insulin vs rosiglitazone for type 2 diabetes treatment. Insulin is injectable short-acting, rosiglitazone is oral with CV and HF risks.
Für diese Seite sind keine Vergleichsdimensionen verfügbar.
Klinischer Kontext
This comparison arises for type 2 diabetes patients considering thiazolidinedione therapy versus starting insulin.
Fazit
Insulin is more versatile and preferred for broader use while rosiglitazone has significant safety limitations.
Alle Medikamentenvergleiche